Skip to main content
Top
Published in: Supportive Care in Cancer 2/2004

01-02-2004 | Original Article

Perceptions of upper-body problems during recovery from breast cancer treatment

Authors: Louisa G. Collins, Robyn Nash, Tracey Round, Beth Newman

Published in: Supportive Care in Cancer | Issue 2/2004

Login to get access

Abstract

Despite improved recognition recently, restrictions in upper-body movement continue to cause impairment and distress for many women long after breast cancer treatment. The purpose of this research is to investigate this issue through the perceptions of breast cancer survivors in the context of their everyday lives. Twenty-four women recruited from a private breast clinic in south-eastern Queensland, Australia, participated in a qualitative study. Discussion groups comprised women treated for breast cancer within the previous 18 months. Discussions centred on experiences of physical difficulties, follow-up support, arm lymphoedema and exercise therapy during the women’s recoveries. Returning to normal activities for women after breast surgery was felt to take longer than either the women’s or their physicians’ expectations. Many women reported difficulties in upper-body tasks, which worsened simple everyday responsibilities. The physical impact leads to psychological strain, as the women are constantly reminded of their illness and the possibility they may never return to their full capacity. These upper-body difficulties may include discomfort while driving and sleeping, posture disturbances, reduced employability in physical work, and decreased ability to do housework and gardening. Having lymphoedema or the threat of developing it was very distressing for most women. The potential preventive role of physiotherapy-led exercises to prevent further decline and improve function was strongly emphasised during these discussions. Clinicians need to recognise that it is very common for women with breast cancer to experience upper-body morbidity long after their treatment, and consequently every effort to enhance recovery and avoid further deterioration in function is required.
Literature
1.
go back to reference Australian Institute of Health and Welfare (1999) Breast cancer in Australian women 1982–1996. National Health and Medical Research Council, Canberra Australian Institute of Health and Welfare (1999) Breast cancer in Australian women 1982–1996. National Health and Medical Research Council, Canberra
2.
go back to reference Bosompra K, Ashikaga T, O’Brien PJ, Nelson L, Skelly J Beatty DJ (2002) Knowledge about preventing and managing lymphedema: a survey of recently diagnosed and treated breast cancer patients. Patient Educ Couns 47:155–163PubMed Bosompra K, Ashikaga T, O’Brien PJ, Nelson L, Skelly J Beatty DJ (2002) Knowledge about preventing and managing lymphedema: a survey of recently diagnosed and treated breast cancer patients. Patient Educ Couns 47:155–163PubMed
3.
go back to reference Bowling A (2000) Research methods: investigating health and health services. Open University Press, Buckingham Bowling A (2000) Research methods: investigating health and health services. Open University Press, Buckingham
4.
go back to reference Box RC, Reul-Hirche HM, Bullock-Saxton JE Furnival CM (2002) Physiotherapy after breast cancer surgery: results of a randomised controlled study to minimise lymphoedema. Breast Cancer Res Treat 75:51–64PubMed Box RC, Reul-Hirche HM, Bullock-Saxton JE Furnival CM (2002) Physiotherapy after breast cancer surgery: results of a randomised controlled study to minimise lymphoedema. Breast Cancer Res Treat 75:51–64PubMed
5.
go back to reference Box RC, Reul-Hirche HM, Bullock-Saxton JE Furnival CM (2002) Shoulder movement after breast cancer surgery: results of a randomised controlled study of postoperative physiotherapy. Breast Cancer Res Treat 75:35–50PubMed Box RC, Reul-Hirche HM, Bullock-Saxton JE Furnival CM (2002) Shoulder movement after breast cancer surgery: results of a randomised controlled study of postoperative physiotherapy. Breast Cancer Res Treat 75:35–50PubMed
6.
go back to reference Breast Cancer Network Australia (2000) Priority research questions identified by Breast Cancer Network Australia. Breast Cancer Network Australia, www.bcna.org.au/research. Cited 12 Sept 2000 Breast Cancer Network Australia (2000) Priority research questions identified by Breast Cancer Network Australia. Breast Cancer Network Australia, www.bcna.org.au/research. Cited 12 Sept 2000
7.
go back to reference Burak WE, Hollenbeck ST, Zervos EE, Hock KL, Kemp LC Young DC (2002) Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer. Am J Surg 183:23–27PubMed Burak WE, Hollenbeck ST, Zervos EE, Hock KL, Kemp LC Young DC (2002) Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer. Am J Surg 183:23–27PubMed
8.
go back to reference Chetty U, Jack W, Prescott RJ, Tyler C Rodger A (2000) Management of the axilla in operable breast cancer treated by breast conservation: a randomized clinical trial. Edinburgh Breast Unit. Br J Surg 87:163–169PubMed Chetty U, Jack W, Prescott RJ, Tyler C Rodger A (2000) Management of the axilla in operable breast cancer treated by breast conservation: a randomized clinical trial. Edinburgh Breast Unit. Br J Surg 87:163–169PubMed
9.
go back to reference Davis C, Williams P Redman S (2000) Early discharge following breast surgery: assessing care, support, and informational needs of women with early breast cancer in Australia. Aust N Z J Surg 70:569–572PubMed Davis C, Williams P Redman S (2000) Early discharge following breast surgery: assessing care, support, and informational needs of women with early breast cancer in Australia. Aust N Z J Surg 70:569–572PubMed
10.
go back to reference Edwards TL (2000) Prevalence and aetiology of lymphoedema after breast cancer treatment in southern Tasmania. Aust N Z J Surg 70:412–418PubMed Edwards TL (2000) Prevalence and aetiology of lymphoedema after breast cancer treatment in southern Tasmania. Aust N Z J Surg 70:412–418PubMed
11.
go back to reference Ganz PA (2000) Quality of life across the continuum of breast cancer care. Breast J 6:324–330PubMed Ganz PA (2000) Quality of life across the continuum of breast cancer care. Breast J 6:324–330PubMed
12.
go back to reference Gaskin TA, LoBuglio A, Kelly P, Doss M Pizitz N (1989) STRETCH: a rehabilitative program for patients with breast cancer. South Med J 82:467–469PubMed Gaskin TA, LoBuglio A, Kelly P, Doss M Pizitz N (1989) STRETCH: a rehabilitative program for patients with breast cancer. South Med J 82:467–469PubMed
13.
go back to reference Gerber LH Augustine EM (2000) Rehabilitation management: restoring fitness and return to functional activity. In: Harris JR (eds) Diseases of the breast. Lippincott, Philadelphia, pp 1001–1007 Gerber LH Augustine EM (2000) Rehabilitation management: restoring fitness and return to functional activity. In: Harris JR (eds) Diseases of the breast. Lippincott, Philadelphia, pp 1001–1007
14.
go back to reference Haid A, Koberle-Wuhrer R, Knauer M, Burtscher J, Fritzsche H, Peschina W, Jasarevic Z, Ammann M, Hergan K, Sturn H Zimmermann G (2002) Morbidity of breast cancer patients following complete axillary dissection or sentinel node biopsy only: a comparative evaluation. Breast Cancer Res Treat 73:31–36PubMed Haid A, Koberle-Wuhrer R, Knauer M, Burtscher J, Fritzsche H, Peschina W, Jasarevic Z, Ammann M, Hergan K, Sturn H Zimmermann G (2002) Morbidity of breast cancer patients following complete axillary dissection or sentinel node biopsy only: a comparative evaluation. Breast Cancer Res Treat 73:31–36PubMed
15.
go back to reference Hare M (2000) The lived experience of breast cancer-related lymphoedema. Nurs Stand 15:35–39 Hare M (2000) The lived experience of breast cancer-related lymphoedema. Nurs Stand 15:35–39
16.
go back to reference Harris SR Niesen-Vertommen SL (2000) Challenging the myth of exercise-induced lymphedema following breast cancer: a series of case reports. J Surg Oncol 74:95–98; discussion 98–99PubMed Harris SR Niesen-Vertommen SL (2000) Challenging the myth of exercise-induced lymphedema following breast cancer: a series of case reports. J Surg Oncol 74:95–98; discussion 98–99PubMed
17.
go back to reference Hladiuk M, Huchcroft S, Temple W Schnurr BE (1992) Arm function after axillary dissection for breast cancer: a pilot study to provide parameter estimates. J Surg Oncol 50:47–52PubMed Hladiuk M, Huchcroft S, Temple W Schnurr BE (1992) Arm function after axillary dissection for breast cancer: a pilot study to provide parameter estimates. J Surg Oncol 50:47–52PubMed
18.
go back to reference Johansson K, Ohlsson K, Ingvar C, Albertsson M Ekdahl C (2002) Factors associated with the development of arm lymphedema following breast cancer treatment: a match pair case-control study. Lymphology 35:59–71PubMed Johansson K, Ohlsson K, Ingvar C, Albertsson M Ekdahl C (2002) Factors associated with the development of arm lymphedema following breast cancer treatment: a match pair case-control study. Lymphology 35:59–71PubMed
19.
go back to reference Keramopoulos A, Tsionou C, Minaretzis D, Michalas S Aravantinos D (1993) Arm morbidity following treatment of breast cancer with total axillary dissection: a multivariated approach. Oncology 50:445–449PubMed Keramopoulos A, Tsionou C, Minaretzis D, Michalas S Aravantinos D (1993) Arm morbidity following treatment of breast cancer with total axillary dissection: a multivariated approach. Oncology 50:445–449PubMed
20.
go back to reference Kuehn T, Klauss W, Darsow M, Regele S, Flock F, Maiterth C, Dahlbender R, Wendt I Kreienberg R (2000) Long-term morbidity following axillary dissection in breast cancer patients—clinical assessment, significance for life quality and the impact of demographic, oncologic and therapeutic factors. Breast Cancer Res Treat 64:275–286PubMed Kuehn T, Klauss W, Darsow M, Regele S, Flock F, Maiterth C, Dahlbender R, Wendt I Kreienberg R (2000) Long-term morbidity following axillary dissection in breast cancer patients—clinical assessment, significance for life quality and the impact of demographic, oncologic and therapeutic factors. Breast Cancer Res Treat 64:275–286PubMed
21.
go back to reference Kwan W, Jackson J, Weir LM, Dingee C, McGregor G Olivotto IA (2002) Chronic arm morbidity after curative breast cancer treatment: prevalence and impact on quality of life. J Clin Oncol 20:4242–4248PubMed Kwan W, Jackson J, Weir LM, Dingee C, McGregor G Olivotto IA (2002) Chronic arm morbidity after curative breast cancer treatment: prevalence and impact on quality of life. J Clin Oncol 20:4242–4248PubMed
22.
go back to reference Lash TL Silliman RA (2000) Patient characteristics and treatments associated with a decline in upper-body function following breast cancer therapy. J Clin Epidemiol 53:615–622PubMed Lash TL Silliman RA (2000) Patient characteristics and treatments associated with a decline in upper-body function following breast cancer therapy. J Clin Epidemiol 53:615–622PubMed
23.
go back to reference Liljegren G Holmberg L (1997) Arm morbidity after sector resection and axillary dissection with or without postoperative radiotherapy in breast cancer stage I. Results from a randomised trial. Uppsala-Orebro Breast Cancer Study Group. Eur J Cancer 33:193–199CrossRefPubMed Liljegren G Holmberg L (1997) Arm morbidity after sector resection and axillary dissection with or without postoperative radiotherapy in breast cancer stage I. Results from a randomised trial. Uppsala-Orebro Breast Cancer Study Group. Eur J Cancer 33:193–199CrossRefPubMed
24.
go back to reference Maunsell E, Brisson J Deschenes L (1993) Arm problems and psychological distress after surgery for breast cancer. Can J Surg 36:315–320PubMed Maunsell E, Brisson J Deschenes L (1993) Arm problems and psychological distress after surgery for breast cancer. Can J Surg 36:315–320PubMed
25.
go back to reference Meric F, Buchholz TA, Mirza NQ, Vlastos G, Ames FC, Ross MI, Pollock RE, Singletary SE, Feig BW, Kuerer HM, Newman LA, Perkins GH, Strom EA, McNeese MD, Hortobagyi GN Hunt KK (2002) Long-term complications associated with breast-conservation surgery and radiotherapy. Ann Surg Oncol 9:543–549PubMed Meric F, Buchholz TA, Mirza NQ, Vlastos G, Ames FC, Ross MI, Pollock RE, Singletary SE, Feig BW, Kuerer HM, Newman LA, Perkins GH, Strom EA, McNeese MD, Hortobagyi GN Hunt KK (2002) Long-term complications associated with breast-conservation surgery and radiotherapy. Ann Surg Oncol 9:543–549PubMed
26.
go back to reference Mock V, Dow KH, Meares CJ, Grimm PM, Dienemann JA, Haisfield-Wolfe ME, Quitasol W, Mitchell S, Chakravarthy A Gage I (1997) Effects of exercise on fatigue, physical functioning, and emotional distress during radiation therapy for breast cancer. Oncol Nurs Forum 24:991–1000 Mock V, Dow KH, Meares CJ, Grimm PM, Dienemann JA, Haisfield-Wolfe ME, Quitasol W, Mitchell S, Chakravarthy A Gage I (1997) Effects of exercise on fatigue, physical functioning, and emotional distress during radiation therapy for breast cancer. Oncol Nurs Forum 24:991–1000
27.
go back to reference National Breast Cancer Centre (2001) Breast cancer incidence from 1982 to 1997 and mortality to 1999 in Australian women. National Breast Cancer Centre, http://www.nbcc.org.au/pages/info/stats/incidence/index.htm. Cited 12 Jan 2003 National Breast Cancer Centre (2001) Breast cancer incidence from 1982 to 1997 and mortality to 1999 in Australian women. National Breast Cancer Centre, http://​www.​nbcc.​org.​au/​pages/​info/​stats/​incidence/​index.​htm.​ Cited 12 Jan 2003
28.
go back to reference QSR (2000) NUD*IST: Non-numeric Unstructured Data, Index Searching and Theorising. QSR International Pty Ltd, Brisbane QSR (2000) NUD*IST: Non-numeric Unstructured Data, Index Searching and Theorising. QSR International Pty Ltd, Brisbane
29.
go back to reference Satariano WA Ragland DR (1996) Upper-body strength and breast cancer: a comparison of the effects of age and disease. J Gerontol A Biol Sci Med Sci 51:M215–219PubMed Satariano WA Ragland DR (1996) Upper-body strength and breast cancer: a comparison of the effects of age and disease. J Gerontol A Biol Sci Med Sci 51:M215–219PubMed
30.
go back to reference Schrenk P, Rieger R, Shamiyeh A Wayand W (2000) Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 88:608–614CrossRefPubMed Schrenk P, Rieger R, Shamiyeh A Wayand W (2000) Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 88:608–614CrossRefPubMed
31.
go back to reference Shimozuma K, Ganz PA, Petersen L Hirji K (1999) Quality of life in the first year after breast cancer surgery: rehabilitation needs and patterns of recovery. Breast Cancer Research and Treatment 56:45–57PubMed Shimozuma K, Ganz PA, Petersen L Hirji K (1999) Quality of life in the first year after breast cancer surgery: rehabilitation needs and patterns of recovery. Breast Cancer Research and Treatment 56:45–57PubMed
32.
go back to reference Tasmuth T, von Smitten K Kalso E (1996) Pain and other symptoms during the first year after radical and conservative surgery for breast cancer. Br J Cancer 74:2024–2031PubMed Tasmuth T, von Smitten K Kalso E (1996) Pain and other symptoms during the first year after radical and conservative surgery for breast cancer. Br J Cancer 74:2024–2031PubMed
Metadata
Title
Perceptions of upper-body problems during recovery from breast cancer treatment
Authors
Louisa G. Collins
Robyn Nash
Tracey Round
Beth Newman
Publication date
01-02-2004
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 2/2004
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-003-0554-5

Other articles of this Issue 2/2004

Supportive Care in Cancer 2/2004 Go to the issue

Society News

February 2004

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine